Showing results (181-190 of 189) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Journal of Pharmaceutical Sciences|March 18, 2014
Investigation of the mechanism of racemization of litronesib in aqueous solution: unexpected base-catalyzed inversion of a fully substituted carbon chiral centerSteven W Baertschi, Patrick J Jansen, Robert M Montgomery, et al.Journal of Medicinal Chemistry|June 1, 2026
Structural Modification and Development of <i>N</i>-(1,2,3,4-Tetrahydro-3-isoquinolinylmethyl)benzamide, BPR1M492, as a Potent and Rapid-Onset Opioid Analgesic with Reduced Withdrawal SymptomsPo-Wei Chang, Yung-Chiao Chang, Ya-Wen Tien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, et al.Brain, Behavior, and Immunity|September 8, 2023
Voluntary wheel exercise ameliorates cognitive impairment, hippocampal neurodegeneration and microglial abnormalities preceded by demyelination in a male mouse model of noise-induced hearing lossHong Zhuang, Qian Li, Congli Sun, et al.Molecular Cancer Therapeutics|April 9, 2024
Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with EverolimusChun-Ping Chang, Teng-Kuang Yeh, Chiung-Tong Chen, et al.BMJ Open|April 2, 2021
Predicting mortality in acute ischaemic stroke treated with mechanical thrombectomy: analysis of a multicentre prospective registryHao Li, Shi-Sheng Ye, Yuan-Ling Wu, et al.Journal of Medicinal Chemistry|October 30, 2024
DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral AdministrationShu-Yu Lin, Yung-Chiao Chang, Ya-Wen Tien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell LymphomaAnas Younes, Laurie H Sehn, Peter Johnson, et al.Lancet (London, England)|June 27, 2021
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label studyJesus G Berdeja, Deepu Madduri, Saad Z Usmani, et al.Pageof 19